Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v8-FR Version v7-EN
Language French English
Date Updated 2022-12-16 2022-12-16
Drug Identification Number 02245248 02245248
Brand name AMIODARONE HYDROCHLORIDE INJECTION AMIODARONE HYDROCHLORIDE INJECTION
Common or Proper name AMIODARONE HYDROCHLORIDE INJECTION AMIODARONE HYDROCHLORIDE INJECTION
Company Name FRESENIUS KABI CANADA LTD FRESENIUS KABI CANADA LTD
Ingredients AMIODARONE HYDROCHLORIDE AMIODARONE HYDROCHLORIDE
Strength(s) 50MG 50MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS INTRAVENOUS INTRAVENOUS
Packaging size 3 mL 3 mL
ATC code C01BD C01BD
ATC description ANTIARRHYTHMICS, CLASS I AND III ANTIARRHYTHMICS, CLASS I AND III
Reason for shortage Disruption of the manufacture of the drug. Disruption of the manufacture of the drug.
Anticipated start date 2022-08-02 2022-08-02
Actual start date 2022-12-09 2022-12-09
Estimated end date Unknown Unknown
Actual end date
Shortage status Actual shortage Actual shortage
Tier 3 Status No No
Company comments On 100% allocation. On 100% allocation.
Health Canada comments